We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ecsc Group Plc | LSE:ECSC | London | Ordinary Share | GB00BYMJ4J99 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 52.50 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 52.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/6/2023 | 07:00 | UKREG | AIM Cancellation - ECSC Group plc |
| 22/6/2023 | 19:33 | ALNC |  TRADING UPDATES: Scheme of arrangement for ECSC takeover passes |
| 22/6/2023 | 12:24 | UKREG | ECSC Group PLC Scheme of Arrangement becomes effective |
| 22/6/2023 | 07:30 | UKREG | AIM Suspension - ECSC Group plc |
| 20/6/2023 | 17:10 | ALNC | IN BRIEF: ECSC shares to be cancelled on Friday following takeover |
| 20/6/2023 | 16:48 | UKREG | ECSC Group PLC Court sanction of Scheme of Arrangement |
| 19/6/2023 | 18:00 | UKREG | FTSE Russell ECSC Group |
| 01/6/2023 | 19:42 | ALNC | IN BRIEF: ECSC says hearing scheduled for June 20 to effect takeover |
| 01/6/2023 | 16:40 | UKREG | ECSC Group PLC Clearance granted under the NS&I Act |
| 24/5/2023 | 16:50 | UKREG | ECSC Group PLC Results of Court Meeting and General Meeting |
Ecsc (ECSC) Share Charts1 Year Ecsc Chart |
|
1 Month Ecsc Chart |
Intraday Ecsc Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 07/7/2023 | 10:17 | ECSC Group Blue chip cyber security | 625 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 26/6/2023 09:45 by maddox rns 22 June 2023'Settlement Under the terms of the Scheme, Scheme Shareholders on the register of members of ECSC at the Scheme Record Time, being 6.00 p.m. on 21 June 2023, are entitled to receive 54.02 pence in cash for every Scheme Share held. Cheques will be dispatched to Scheme Shareholders holding Scheme Shares in certificated form and the CREST accounts of Scheme Shareholders holding Scheme Shares in uncertificated form will be credited within 14 days of today's date.' |
Posted at 03/4/2023 09:03 by private38 Sad to see this go but the sector is painfully competitive with the likes of Arctic Wolf etc ripping through the market destroying any pricing power due to their massive marketing and sales budgets and "win the client at any cost attitude" these super niche players like ECSC have an increasingly tough row to hoe. Scale or sell are probably the only two options with the former being high risk. The consolidation of this sector is happening and I expect the likes of Falanx to follow. Darwinian. |
Posted at 02/4/2023 22:56 by cerrito At this stage, subject to the approval and availability of the Court (which is subject to change), Daisy and ECSC expect the Scheme to become Effective at the beginning of June 2023. |
Posted at 31/3/2023 15:41 by cerrito The reality is that given the NCC news today and the performance of my other cyber security holding CCS we should not count on a higher offer and be glad that we have got this.I will take a loss as my in price is 63 but could have been worse. |
Posted at 31/3/2023 14:46 by ali47fish so what is the verdict any chance of a better bid- why have the director accepted such a derisory price |
Posted at 31/3/2023 14:16 by 2lb For contextFloated in 2016 , seven years ago, under the following parameters "The Company is proposing to raise approximately £5.0 million (before expenses) through a placing by Stockdale of 2,994,011 New Shares at a price of 167 pence per share. In addition, 519,174 Sale Shares held by the Selling Shareholders will be sold at the Placing Price." Initial £15m MCAP and £5m cash in the bank on admission. Seven years later it is sold for £5m cash having failed to do anything in the interim seven years other than burn through shareholder cash and pay its directors nicely. Nice £167k bonus for offloading it at a 67% discount to placing MCAP for the CEO. All in a market and sector that has boomed over the same time period. An AIM classic of director reward for failure. |
Posted at 31/3/2023 12:59 by jane doe1 He's done nothing, no chance of becoming profitable so they sold out at a cheap price |
Posted at 07/2/2023 14:08 by chrisdgb someone selling clips of 1k shares just hit the price as well..... |
Posted at 01/2/2023 09:03 by gb904150 Not sure that's fair to call it sleight of hand. 3 wins of £690k is quite significant for a company with £3m mcap.More significant is that they are in the MDR division. MDR wins are critical to the success of ECSC and I'd say the recent share price weakness has been due to the MDR pipeline being weak (was around £2.2m last set of results). Covid hit the pipeline as that used to be a face to face selling function whereas now it's more hybrid. In MDR they have high staff costs to cover - highly paid staff that have to cover X hours to. So that division has high operational leverage. When it is low the GM's drop off sharply. When it is high it is much more efficient and with higher GM's. From previous presentations the MDR wins are 3yr contracts, as they are here. There are some setup costs but then give us ARR's. Usually about 1/4 is billed upfront so they are immediately working capital positive. In short, MDR is the profitable, scalable part of the business. The bigger it is the more efficient and higher GM's it is. So I'd say £690k wins there is pretty significant. I'm not saying the forthcoming results will be fantastic, there will be a lag, but MDR is critical to ECSC's recovery and MDR contract wins suggest ECSC is recovering/improving |
Posted at 06/6/2022 23:32 by cerrito I do not see myself making the AGM, especially if there are rail strikes.I have gone through the AR. My first reaction was its length 112 pages which seems OTT for such a small company and must be a barrier for small companies to list. I could not find on their websites their previous AR’s so no idea if they were bigger or smaller. The following caught my eye Page 12 I thought Lucy Sharp’s report read well. Page 25 I saw the useful increase YOY in gross profit from the Assurance and decline in MDR but could find no good explanation of what drove these or indeed what business is in the assurance division and what in the ECR division. Page 27 Be interesting to see if their EBITDA performance was good enough in H1 so they can increase their loan facility and begs the question as to why they need the funds. Page 29 Note two risks have increased-economic conditions and hiring- the rest are no change and no risks have decreased. Page 39 I see that the Chairman spends at least two working days a month on ECSC which I thought should be sufficient, even though he doubles up as Company Secretary. I see on page 42 that both he and Gooch attended all board meetings. Page 43 A very stable shareholder base and indeed the last change of holdings RNS we had was way back in May 2020 after the latest equity issue. One concern I have had and continue to have is what would happen if either Unicorn or Ravinder Bahra wanted to exit. Fingers crossed that both remain if not happy at least satisfied and have no pressing need for cash. As an aside I have just been on the LSE website and seen since close of business on May 25 there have just been 4 transactions with a combined value of £12k in these 6 trading days…granted we did have the jubilee break but even so. Page 46 I see that directors ‘remuneration as a whole fell from £829k to £731k, as one very highly paid director left, in the context that group expenses on employee benefits went up from £4.7m to £5.3m. The increase in expenditure at a group basis understandable given industry trends and no doubt there will be a big increase in 2022. This means that in 2021 directors’ remuneration was 14% of total-a bit high perhaps and certainly better than the 2020 figure of 18%. Note that as per page 87 total average number of employees was 87. Given that in the IMC and other shareholder meetings Ian Mann gives the impression that ECSC is a one man band, I was pleasantly surprised that the differential between his and Lucy Sharp’s remuneration was as low as it was in 2021 and indeed in 2020 they had virtually identical remuneration. Page 47 Let’s hope for all our sakes that the share options of the directors are in the money. Page 80 Probably good that no single client accounts for more than 10% of the revenue. Page 82 I note the reduction in contract liabilities. Given that it was inferred that the amount of 3 year contract work was increasing, this seems counter intuitive. Any views anyone Page 86 Sobering but realistic that no deferred tax asset created quote because the Board envisages that a significant period of time will be required to generate sufficient profits to utilise the trading losses carried forward unquote…the trading losses being £5.4m Page 89 Concerned that so few additions to the computer equipment. Anyone understand how the net book value of computer equipment has gone up from £68k to £658 k during 2021??? Page 97 Not only are the terms of the loan facility very onerous but we learn that there was a 1% fee payable. Page 106 Interesting no share options were granted in 2021. Conclusion Not one of my better decisions to buy ECSC and well done to those who exited at the start of the year. I am suffering the consequences with the share price at current levels. Not sure what will provoke an uptick. Cannot see who would buy them. Any trading improvement will be a hard slog and the loan facility shows their lack of financial flexibility. I note that Allenby are currently forecasting a PBT loss this year 2022 of £308k up from last year’s loss of £277k. My last purchase was in July 2020.While not a Yorkshireman, I will show Yorkshire stubbornness and hang on with the marcap at £9m. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
